Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Paul Savas Insider Profile
4 Followers
Paul Savas, Director at vTv Therapeutics, holds 307.85K shares in SIGA Technologies (Ticker: SIGA), holds 91.78K shares in vTv Therapeutics (Ticker: VTVT), holds 19.80K shares in Revlon (Ticker: REVRQ).
Profitable Transactions
7 out of 17 Profitable Transactions
Average Return
+1.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Paul Savas holds in companies
Most Profitable Insider Trade
The most profitable trade made by Paul Savas
Paul Savas's Trading History
vTv Therapeutics
Sep 06, 2018
Director
Informative Buy
5.00K
$2.27M
Revlon
Nov 14, 2016
―
Informative Buy
232.49K
$1.39K
SIGA Technologies
May 22, 2020
Director
Uninformative Buy
―
$3.20M
List of latest transactions for each holding click on a transaction to see Paul Savas's performance on stock
You May Also Like
Paul Savas insider profile FAQ
What is the percentage of profitable transactions made by Paul Savas?
The percentage of profitable transactions made by Paul Savas is 41%.
What is the average return per transaction made by Paul Savas?
The average return per transaction made by Paul Savas is 1.20%.
What stocks does Paul Savas hold?
Paul Savas holds: VTVT, REVRQ, SIGA stocks.
What was Paul Savas’s latest transaction?
Paul Savas latest transaction was an Uninformative Buy of ―.
What was Paul Savas's most profitable transaction?
Paul Savas’s most profitable transaction was an Informative Buy of SIGA stock on November 18, 2016. The return on the trade was 87.50%.
What is Paul Savas's role in vTv Therapeutics?
Paul Savas's role in vTv Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.